
2.7K
Downloads
67
Episodes
The World Stroke Academy podcast offers interviews with key figures in the field of stroke research and highlights current topics and issues. Join us as we delve into the latest advancements in stroke care, diagnosis, treatment, and rehabilitation. Our expert guests, including leading neurologists, researchers, and clinicians, share their expertise and experiences to keep you up-to-date with the ever-evolving field of stroke management. Whether you’re a seasoned practitioner or a passionate student, our podcast offers a deep dive into critical topics, case studies, and innovative approaches that can enhance your skills and improve patient outcomes. Tune in regularly to expand your expertise, connect with peers worldwide, and make a significant impact on stroke care. Welcome to the World Stroke Academy Podcast – where knowledge meets action in the fight against stroke.
The World Stroke Academy podcast offers interviews with key figures in the field of stroke research and highlights current topics and issues. Join us as we delve into the latest advancements in stroke care, diagnosis, treatment, and rehabilitation. Our expert guests, including leading neurologists, researchers, and clinicians, share their expertise and experiences to keep you up-to-date with the ever-evolving field of stroke management. Whether you’re a seasoned practitioner or a passionate student, our podcast offers a deep dive into critical topics, case studies, and innovative approaches that can enhance your skills and improve patient outcomes. Tune in regularly to expand your expertise, connect with peers worldwide, and make a significant impact on stroke care. Welcome to the World Stroke Academy Podcast – where knowledge meets action in the fight against stroke.
Episodes

Sunday May 10, 2026
Sunday May 10, 2026
Episode 2 of the World Stroke Academy vodcast series: 'Rethinking Secondary Stroke Prevention - The Factor XI-XIa Inhibition Era'. Inside OCEANIC-Stroke: Design, Results and Key Insights with Prof. Mike Sharma, interviewed by Prof. Octavio Pontes Neto. Supported by an unrestricted grant by Bayer AG.

No comments yet. Be the first to say something!